漢港控股(01663.HK)附屬實驗室成功通過CMA檢驗檢測機構資質認定證書變更申請
格隆匯4月7日丨 漢港控股(01663.HK)公吿,公司旗下子公司浙江美測醫藥科技有限公司("浙江美測")於4月1日成功通過CMA檢驗檢測機構資質認定證書變更申請。由於浙江美測實驗室於2021年9月遷移杭州醫藥港,基於場地的變更,浙江美測CMA證書也需要進行相應的變更,而這種變更的評審嚴格程度與初次申請相差無幾。
CMA檢驗檢測機構資質認定是依據《中華人民共和國計量法》、《中華人民共和國認證認可條例》等法律法規,針對在中華人民共和國境內從事為社會提供公正數據和結果的產品質量檢驗檢測機構的市場準入制度。
此次順利通過CMA證書變更申請,表明浙江美測實驗室已具備了按相應認可準則開展CMA計量檢測認證服務的技術能力,具備了對外出具公正性報吿的資質能力,對浙江美測在醫藥行業影響力和品牌提升等方面都會產生積極的影響,同時為浙江美測進一步規範行業標準質量管理、拓展業務、擴大信譽度和權威性,併為客户提供更全面的服務打下堅實的基礎,也標誌着浙江美測實驗室的技術能力和管理水平上升了一個新台階,將為浙江美測客户的發展貢獻更大的力量。
繼獲得新的CNAS認可證書後,浙江美測成功通過CMA檢驗檢測機構資質認定證書變更申請,是對浙江美測實驗室的技術水平的再次肯定。集團相信,隨着獲取相關的資格證書更新,配合浙江美測新實驗室的高精頂尖儀器設備、更全面的專業技術人才和更強大的研發團隊,定必能加快推進本集團全面開展整體藥學研究服務,為本集團業務帶來業務營運和收益效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.